Imricor Medical Systems Inc (IMR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has a cash flow conversion efficiency ratio of -0.198x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.56 Million ≈ $-3.23 Million USD) by net assets (AU$23.08 Million ≈ $16.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Imricor Medical Systems Inc - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Imricor Medical Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Imricor Medical Systems Inc (IMR) total liabilities for a breakdown of total debt and financial obligations.
Imricor Medical Systems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Imricor Medical Systems Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EUROKAI GmbH & Co. KGaA
F:EUK3
|
0.017x |
|
Zhongtong Guomai Communication
SHG:603559
|
-0.131x |
|
Huang Hsiang Construction Corp
TW:2545
|
-0.192x |
|
Iteos Therapeutics Inc
NASDAQ:ITOS
|
-0.086x |
|
Ram Ratna Wires Limited
NSE:RAMRAT
|
0.019x |
|
Ganso Co Ltd
SHG:603886
|
0.101x |
|
Hankook Shell Oil
KO:002960
|
0.127x |
|
Tadiran Hldg
TA:TDRN
|
0.100x |
Annual Cash Flow Conversion Efficiency for Imricor Medical Systems Inc (2016–2024)
The table below shows the annual cash flow conversion efficiency of Imricor Medical Systems Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see IMR stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$-7.38 Million ≈ $-5.22 Million |
AU$-15.57 Million ≈ $-11.02 Million |
2.111x | +42.40% |
| 2023-12-31 | AU$-8.75 Million ≈ $-6.19 Million |
AU$-12.98 Million ≈ $-9.18 Million |
1.483x | +167.44% |
| 2022-12-31 | AU$7.51 Million ≈ $5.31 Million |
AU$-16.51 Million ≈ $-11.68 Million |
-2.198x | -181.58% |
| 2021-12-31 | AU$22.40 Million ≈ $15.85 Million |
AU$-17.49 Million ≈ $-12.37 Million |
-0.781x | -83.94% |
| 2020-12-31 | AU$28.82 Million ≈ $20.39 Million |
AU$-12.23 Million ≈ $-8.65 Million |
-0.424x | +54.96% |
| 2019-12-31 | AU$7.03 Million ≈ $4.98 Million |
AU$-6.63 Million ≈ $-4.69 Million |
-0.942x | -100.20% |
| 2018-12-31 | AU$13.47 Million ≈ $9.53 Million |
AU$-6.34 Million ≈ $-4.49 Million |
-0.471x | -143.77% |
| 2017-12-31 | AU$-5.25 Million ≈ $-3.72 Million |
AU$-5.65 Million ≈ $-4.00 Million |
1.075x | +6.98% |
| 2016-12-31 | AU$-4.03 Million ≈ $-2.85 Million |
AU$-4.05 Million ≈ $-2.87 Million |
1.005x | -- |
About Imricor Medical Systems Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include… Read more